Severe trachomatous dry eye treatment

Article

Dr Mustafa Guzey and colleagues have found topical cyclosporine A to be effective in treating severe trachomatous dry eye in a recent study published in Clinical & Experimental Ophthalmology.

Dr Mustafa Guzey and colleagues have found topical cyclosporine A to be effective in treating severe trachomatous dry eye in a recent study published in Clinical & Experimental Ophthalmology.

In an author commentary published on MDLinx Dr Guzey confirmed that whilst there is no therapeutic treatment available at the moment for severe trachomatous dry eye: "In preliminary studies, treatment with topical CsA improved the signs and the symptoms of dry eye syndrome. An increase in goblet cell counts was reported in association with clinical improvement. Reduced numbers of activated T lymphocytes in conjunctiva and a decrease in IL's in conjunctival epithelium were also observed. CsA significantly improved corneal staining, Schirmer scores and significantly increased conjunctival goblet cell density."

Sixty four patients were included in the study and 32 were treated with CsA 0.05% ophthalmic emulsion twice daily and concomitant 5 times daily non-preserved artificial tear and the other 32 were designated as the control group receiving placebo emulsion twice daily and non-preserved artificial tear 5 times daily.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.